C

Commence

Transforms health data into AI-ready insights

Overview

Commence turns unstructured health data from records, claims, and notes into structured, AI-ready data to support decision-making for federal, state, and commercial health programs. Its Amplify platform modularly covers Capture (digitize/standardize), Review (AI classify/summarize), and Clarity (pattern/risk insights), used alone or together with expert oversight from 500+ licensed clinicians. It differentiates itself by combining end-to-end data transformation with clinical review and government-focused workflows, delivering interoperable data-to-decision solutions for program integrity, medical reviews, payments, and quality improvement. Its goal is to improve health outcomes by turning data into actionable insights and efficient operations for public and commercial health partners.

Work here?Claim your company

About Commence

Simplify's Rating
Why Commence is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsGovernment & Public SectorAI & Machine LearningHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Virginia Beach, Virginia

Founded

N/A

Get referred to Commence

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 brought Greg Davis, strengthening federal sales execution and capture.
  • Commence won CMS RMADA 3 placement and new VA, DHA modernization awards.
  • The company serves 60% of Medicare patients across 27 states, creating scale advantages.

What critics are saying

  • Federal budget and policy changes already delayed Commence’s growth plans in 2025.
  • Heavy CMS, VA, and DHA exposure ties revenue to federal procurement cycles.
  • AI health-data rivals like Cotiviti and Optum push deeper into reviews and program integrity.

What makes Commence unique

  • May 2025 merger joined DOMA, Livanta, and Advanta into one federal-health platform.
  • Amplify launched July 2025, unifying Capture, Review, and Clarity for health-data workflows.
  • Over 500 licensed clinicians add human review to AI-driven medical record transformation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Associated Press
Sep 2nd, 2026
Commence appoints Greg Davis as chief growth officer to scale federal health business

Commence, a health services and technology platform backed by Pleasant Land, has appointed Greg Davis as Chief Growth Officer. Davis will oversee expansion of the company's public sector and commercial operations. Davis joins from GDIT, where he served as Vice President of Federal Health, leading a $1.3 billion line of business. Previously at Booz Allen Hamilton, he grew the firm's NIH account from approximately $70 million to $150 million in annual revenue. The appointment follows recent contract wins, including a position on the CMS Research, Measurement, Assessment, Design, and Analysis 3 vehicle, plus new awards supporting modernisation efforts at the Department of Veterans Affairs and Defense Health Agency. Davis replaces Nick Marchand, who is moving to a Chief Strategy Officer role at Pleasant Land.

Recently Posted Jobs

Sign up to get curated job recommendations

Commence is Hiring for 25 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs